Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications
Rajkumar Singh Kalra, Jaspreet Kaur Dhanjal, Avtar S. Meena, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges
Saikat Dewanjee, Ramesh Kandimalla, Rajkumar Singh Kalra, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3291-3291
Open Access | Times Cited: 54
Revealing the mystery of persistent smell loss in long COVID patients
Jung Woo Park, Xiaoyan Wang, Ren‐He Xu
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4795-4808
Open Access | Times Cited: 28
COVID-19 as a Risk Factor for Alzheimer’s Disease
Mahdieh Golzari-Sorkheh, Donald F. Weaver, Mark A. Reed
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 1, pp. 1-23
Open Access | Times Cited: 27
The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders
Gunel Ayyubova, Sergiy G. Gychka, Sofia I. Nikolaienko, et al.
Life (2024) Vol. 14, Iss. 2, pp. 279-279
Open Access | Times Cited: 4
A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2
Dominika Bedran, Georges Bedran, Sachin Kote
Vaccines (2024) Vol. 12, Iss. 3, pp. 222-222
Open Access | Times Cited: 4
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
Ramesh Kandimalla, Pratik Chakraborty, V. Jayalakshmi, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1740-1740
Open Access | Times Cited: 24
Healthy Immunity on Preventive Medicine for Combating COVID-19
Pulak R. Manna, Zackery C. Gray, P. Hemachandra Reddy
Nutrients (2022) Vol. 14, Iss. 5, pp. 1004-1004
Open Access | Times Cited: 17
Olfactory training for olfactory dysfunction in COVID‐19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic
Pooja Ojha, Abhinav Dixit
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 4, pp. 462-473
Closed Access | Times Cited: 16
Insomnia among coronavirus disease 2019 survivors: A single-center cross-sectional study
Man-Lu Lu, Zhu Jiwei, Jing-Lin Wu, et al.
Medicine (2024) Vol. 103, Iss. 7, pp. e37311-e37311
Open Access | Times Cited: 2
SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology
Serigne Fallou Wade, Abou Abdallah Malick Diouara, Babacar Ngom, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 540-540
Open Access | Times Cited: 2
A Comprehensive Review on Navigating the Neurological Landscape of COVID-19: Insights Into Etiopathogenesis and Clinical Management
Roma Chavhan, Anil Wanjari, Sunil Kumar, et al.
Cureus (2024)
Open Access | Times Cited: 2
The Role of Furin on the Pathogenesis of COVID-19 Associated Neurological Disorders
Gunel Ayyubova, Sergiy G. Gychka, Sofia I. Nikolaienko, et al.
(2024)
Open Access | Times Cited: 1
Task-specific facial dystonia following COVID-19 infection: A case report
Jong‐Mok Lee, Pan‐Woo Ko
Medicine (2024) Vol. 103, Iss. 37, pp. e39689-e39689
Open Access | Times Cited: 1
Probiotics in Inflammatory Bowel Diseases
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 187-207
Closed Access | Times Cited: 1
Pathological Sequelae of SARS-CoV-2: A Review for Clinicians
Joseph Nyarko, Patience Mawuena Dogbe, Lawrencia Ami Emefa Ativi, et al.
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 4, pp. 431-445
Open Access | Times Cited: 1
COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging association, therapeutic options, and challenges
Ramesh Kandimalla, Saikat Dewanjee, Rajkumar Singh Kalra, et al.
(2021)
Open Access | Times Cited: 12
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
Ming‐Shao Tsai, Yao‐Hsu Yang, Yu‐Shih Lin, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 112011-112011
Open Access | Times Cited: 10
https://actascientific.com/ASOR/pdf/ASOR-06-0704.pdf
Ray Marks
Acta Scientific Orthopaedics (2023) Vol. 6, Iss. 3, pp. 126-133
Open Access | Times Cited: 3
The Role of Furin on the Pathogenesis of COVID-19 Associated Neurological Disorders
Gunel Ayyubova, Sergiy G. Gychka, Sofia I. Nikolaienko, et al.
(2023)
Open Access | Times Cited: 2
Association between molecular markers of COVID‐19 and Alzheimer's disease
André Quincozes‐Santos, Rafael Lopes da Rosa, Larissa Daniele Bobermin, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 833-835
Open Access | Times Cited: 5
The bidirectional links between coronavirus disease 2019 and Alzheimer’s disease
Ali Nouraeinejad
International Journal of Neuroscience (2024), pp. 1-9
Closed Access
Resting-state neural dynamics changes in older adults with post-COVID syndrome and the modulatory effect of cognitive training and sex
Boglárka Nagy, Andrea B. Protzner, Balázs Czigler, et al.
GeroScience (2024)
Open Access
SARS-CoV-2 and variants: Alternative therapies to avert COVID-19
Birbal Singh, Gorakh Mal, Rinku Sharma, et al.
Elsevier eBooks (2024), pp. 325-345
Closed Access
Gut-Brain Axis: Probiotics as Psychobiotics
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 357-380
Closed Access
Probiotics as Next-Generation Mucosal Vaccine Vectors
Birbal Singh, Gorakh Mal, Rajkumar Singh Kalra, et al.
(2024), pp. 569-592
Closed Access
Page 1 - Next Page

Scroll to top